Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04262427 |
| Title | The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma (CAPER) |
| Acronym | CAPER |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | The Christie NHS Foundation Trust |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust | RECRUITING | Cambridge | United Kingdom | Details | ||
| Western General Hospital, NHS Lothian | NOT_YET_RECRUITING | Edinburgh | United Kingdom | Details | ||
| Royal Marsden Hospital NHS Foundation Trust | RECRUITING | London | United Kingdom | Details | ||
| The Christie NHS Foundation Trust | RECRUITING | Manchester | United Kingdom | Details |